Concepedia

Publication | Closed Access

Phase IB Study of Vemurafenib in Combination with the Mek Inhibitor, GDC-0973, in Patients (PTS) with Unresectable or Metastatic BRAFV600 Mutated Melanoma (BRIM7)

DOI

21

Citations

0

References

2012

Year

R. Gonzalez, Antoni Ribas, Adil Daud, Anna C. Pavlick, Thomas F. Gajewski, Igor Puzanov, M.S.L. Teng, Iris T. Chan, Nicholas W. Choong, Grant A. McArthur
Annals of Oncology

No additional data available for this publication yet. Check back later!